<DOC>
	<DOCNO>NCT00174538</DOCNO>
	<brief_summary>The objective study determine subject 's genetic make-up would affect treatment response codeine subject sickle cell disease .</brief_summary>
	<brief_title>Codeine Sickle Cell Disease</brief_title>
	<detailed_description>People sickle cell disease require oral pain medication manage acute pain crisis . Sometimes individual fail obtain adequate pain relief medication prescribe outpatient use result emergency room visit hospital admission . Subsequently , many patient admit hospital pain management day pain crisis resolve . The common medication prescribe sickle cell individual outpatient use include codeine hydrocodone contain medication ( i.e . Tylenol # 3™ , Vicodin™ , Lortab™ ) . These medication must break body make active pain reliever ( morphine hydromorphone , respectively ) . Some individual may able break medication active pain reliever ; therefore , individual likely continue experience pain unless take pain medication . We determine whether genotype estimate ability CYP2D6 break codeine active pain reliever individual sickle cell disease .</detailed_description>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Codeine</mesh_term>
	<criteria>Age &gt; = 18 year old Sickle cell disease ( HbSS ) Hydrocodone codeinecontaining medication manage acute pain crisis past Renal dysfunction , serum creatinine ( SCr ) &gt; 2.0 mg/dl Hepatic dysfunction , AST , ALT direct bilirubin &gt; 3 x upper limit normal ( ULN ) Codeine allergy Medications show induce inhibit CYP2D6 Women pregnant breast feeding Unable provide write , inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2005</verification_date>
	<keyword>codeine</keyword>
	<keyword>pain</keyword>
	<keyword>CYP2D6</keyword>
	<keyword>genotype</keyword>
	<keyword>morphine</keyword>
	<keyword>sickle cell</keyword>
	<keyword>pharmacokinetic</keyword>
</DOC>